AARP says certain drug costs could fall 50%

By HME News Staff
Updated 10:05 AM CST, Thu January 8, 2026
WASHINGTON – Out-of-pocket expenses for 10 high-cost prescription drugs are projected to fall by an average of more than 50% for Medicare Part D enrollees when lower prices take effect on Jan. 1, 2026, according to a new analysis released by the AARP. The analysis, conducted in December 2025, examined enrollee cost-sharing and other coverage characteristics among stand-alone Part D plans that were available in five states with high Medicare enrollment. The analysis found that substantial reductions in enrollee cost-sharing will lead to lower monthly out-of-pocket costs for patients, including expected reductions of more than 50% on seven of the 10 drugs analyzed. The AARP’s analysis also found that seven of the 10 drugs are set to cost less than $100 per month – up from only two drugs in 2025 – once new policies to lower drug prices take effect.
Comments